MicroRNA-126 regulates the phosphatidylinositol-3 kinase (PI3K)/protein kinase B (AKT) pathway in SLK cells in vitro and the expression of its pathway members in Kaposi's sarcoma tissue

Medicine
Gaihui LuXiongming Pu

Abstract

In vitro, microRNA-126 (miR-126) inhibits SLK cell proliferation, inhibits the cell cycle, induces cell apoptosis, and reduces cell invasiveness. Double luciferase assays have shown that phosphatidylinositol-3 kinase (PI3K) is the miR-126 target in SLK cells. We aimed to investigate the influence of miR-126 on the phosphate and tension homology deleted on chromosome ten (PTEN)/PI3K/protein kinase B (AKT) pathway members in SLK cells and to determine the expression of these pathway members in Kaposi's sarcoma (KS). The mimic and inhibitor of miR-126 were transfected into SLK cells and PTEN and AKT1 expression was assayed in SLK cells by real-time quantitative PCR and western blotting. PTEN, AKT1, phosphorylated (P)-PTEN, and phosphorylated (P)-AKT expression in KS and paraneoplastic skin were assayed by immunohistochemistry. AKT1 expression was downregulated in SLK cells that overexpressed miR-126, while there was no significant difference in PTEN expression between SLK cells overexpressing miR-126 and those in which its expression was knocked down. PTEN and AKT1 were expressed in KS and paraneoplastic skin but P-AKT was not. Interestingly, P-PTEN was not expressed in paraneoplastic skin but it was expressed in 90% of KS biopsie...Continue Reading

References

Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Mar 30, 2004·Biochemical Society Transactions·Z-Z YangB A Hemmings
May 3, 2006·The Prostate·Celeste L KremerRaymond B Nagle
Sep 23, 2006·Developmental Biology·Baohong ZhangTodd A Anderson
Nov 13, 2007·Biochimica Et Biophysica Acta·Romina MaroneMatthias P Wymann
Jul 22, 2008·Cancer Chemotherapy and Pharmacology·Kristen FosterCynthia Wright
Apr 28, 2009·European Journal of Pharmacology·Soumya S BhattacharyyaAnisur R Khuda-Bukhsh
Jul 15, 2009·Experimental Biology and Medicine·Ronald W Matheny, Martin L Adamo
Jul 25, 2009·Nature Reviews. Cancer·Jeffrey A Engelman
Sep 8, 2010·Developmental Biology·Zai ChangZhongzhou Yang
Aug 14, 2012·Frontiers in Immunology·Jose J Limon, David A Fruman
Sep 13, 2013·Pathology Oncology Research : POR·Ana Maria Catrina EneSakari Knuutila
Oct 1, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiu-Juan WuJian-Yong Liu
May 12, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Rahim GolmohammadiAkbar Pejhan
May 13, 2017·Molecular and Cellular Endocrinology·Patrick D RädlerKay-Uwe Wagner
Jul 9, 2017·Pathology, Research and Practice·Jing LiLi Qin Li
Jul 18, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ondrej FialaJindrich Finek
Jul 26, 2017·Genes & Cancer·Muralidharan JayaramanDanny N Dhanasekaran
Aug 16, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Meilan XueLichen Zhang
Sep 1, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·BaoChun WangNing Liu

❮ Previous
Next ❯

Citations

Oct 13, 2020·Current Opinion in Infectious Diseases·Mildred A Iro, Sudha Priya Soundara Pandi

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
Assay
reverse transcription PCR
electrophoresis
PCR
biopsy
chip

Software Mentioned

Image J
SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.